MIRA INFORM REPORT

 

 

Report No. :

336109

Report Date :

17.08.2015

 

IDENTIFICATION DETAILS

 

Name :

LABORATORIOS ITALDOM SRL

 

 

Registered Office :

Zona Industrial de Herrera – 11005 Santo Domingo Oeste

 

 

Country :

República Dominicana

 

 

Date of Incorporation :

1994

 

 

Legal Form :

Sociedad Anónima

 

 

Line of Business :

Import and distribution of pharmaceutical products.

 

 

No. of Employee :

21

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

República Dominicana

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

REPÚBLICA DOMINICANA ECONOMIC OVERVIEW

 

The Dominican Republic has long been viewed primarily as an exporter of sugar, coffee, and tobacco, but in recent years the service sector has overtaken agriculture as the economy's largest employer, due to growth in telecommunications, tourism, and free trade zones. The mining sector has also played a greater role in the export market since late 2012 with the commencement of the extraction phase of the Pueblo Viejo Gold and Silver mine. The economy is highly dependent upon the US, the destination for approximately half of exports. Remittances from the US amount to about 7% of GDP, equivalent to about a third of exports and two-thirds of tourism receipts. The country suffers from marked income inequality; the poorest half of the population receives less than one-fifth of GDP, while the richest 10% enjoys nearly 40% of GDP. High unemployment and underemployment remains an important long-term challenge. The Central America-Dominican Republic Free Trade Agreement (CAFTA-DR) came into force in March 2007, boosting investment and exports and reducing losses to the Asian garment industry. The Dominican Republic's economy rebounded from the global recession in 2010-14, and the fiscal situation is improving. A tax reform package passed in November 2012 and a reduction in government spending helped to narrow the central government budget deficit from 6.6% of GDP in 2012 to 2.7% in 2014. A successful government bond placement in 2013 and 2014 helped finance the deficit. A liability management operation in January 2015, in which the government paid down over $4 billion of the country’s Petrocaribe debt, at a discount of 52% with proceeds from the sale of $2.5 billion in global bonds, reduced the country’s debt load by approximately by 3.3% of GDP.

 

Source : CIA

 


 

STATUTORY INFORMATION

 

Legal Name:

LABORATORIOS ITALDOM SRL

Trade Name:

LABORATORIO ITALDOM

RNC:

101652381

Date Created:

1994

Date Incorporated:

1994

Legal Address:

Calle 1era No. 4 esq. Juan Ballenilla Urbanización Cinthya
Zona Industrial de Herrera – 11005
Santo Domingo Oeste
República Dominicana

Operative Address:

Calle 1era No. 4 esq. Juan Ballenilla Urbanización Cinthya
Zona Industrial de Herrera – 11005
Santo Domingo Oeste
República Dominicana

Telephone:

1 (809) 534-3540 / (809) 531-8145

Fax:

1 (809) 531-8146

Legal Form:

Sociedad Anónima

Email:

NA

Registered in:

Dominican Republic

Website:

www.laboratoriositaldom.com

Contact:

Ivan Mazzamuto, General Manager

Staff:

21

Activity:

Pharmaceutical Industry Wholesale

 

 

BANKS

Banco Central de la República Dominicana

 

 

 

The company does not disclose its banking data

 

 

History

 

 

The company was founded in 1994

 

 

PRINCIPAL ACTIVITY

 

 

The company is dedicated to the import and distribution of pharmaceutical products.

Products/Services description:

Blisters, alveoli (niches) for eggs, suppositories and pods

Brands:

NA

Sales are:

Wholesale

Clients:

LABORATORIOS BETA SA
Argentina

FUSQUIM SA
Paraguay

ROXFARMA SA
Peru

DALLAS SA
Paraguay

Suppliers:

NA

Operations area:

National and International

The company imports from

It mainly imports from India and Italy.

The company exports to

Latin America

The subject employs

21 employees

Payments:

Regular-30 days payment terms

 

 

LOCATION

 

Headquarters :

Calle 1era No. 4 esq. Juan Ballenilla Urbanización Cinthya
Zona Industrial de Herrera – 11005
Santo Domingo Oeste
República Dominicana

Branches:

The company does not have branches

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO  

Capital:

NA

Shareholders:

The company is owned by Italian shareholders.

Management:

Ivan Mazzamuto, General Manager
Rodolfo Suero, Accountant
Elsi Mateo, Administrative Assistant

Related Companies:

No related companies

 

 

FINANCIAL INFORMATION

 

 

This is a private company which does not make its financial public. The following information has been provided by private sources.

 

 

USD 2014

 

Revenue

500 000

Cash Flow

Normal

 

 

LEGAL FILINGS

 

 

There are no legal connected to the subject

 

 

SUMMARY

 

 

The company is dedicated to the import and distribution of pharmaceutical products.

 

The company has 19 years of experience in the market with a small sized structure.

 

Its sales are médium for its size, but fair for the country’s industry.

 

It mainly imports from Italy, where its shareholders are, and India.

 

There are no negative records connected to the subject. 

 

 

RISK INFORMATION

 

DEBTS

Controlled

PAYMENTS

Regular

CASH FLOW

Normal

STATUS

This Corporation is in Good Standing

 

 

INTERVIEW

 

NAME

Rodolfo Suero

POSITION

Accountant

COMMENTS

He confirmed address, managers, owners, staff, activity, RNC, financial figures.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.12

UK Pound

1

Rs.101.62

Euro

1

Rs.72.56

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.